Pfizer (Australia) SODIUM CHLORIDE 0.9% (450mg/50mL) intravenous infusion

Produktübersicht

About Pfizer (Australia) SODIUM CHLORIDE 0.9% (450mg/50mL) intravenous infusion

Pfizer (Australia) SODIUM CHLORIDE 0. 9% (450mg/50mL) intravenous infusion is a medication containing the active ingredient sodium chloride, classified as alpha-Adrenergic Agonist. Sodium chloride, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. It is transparent or translucent, brittle, hygroscopic, and occurs as the mineral halite.

Key Benefits & Uses

• Used for: INDICATIONS: May temporarily relieve sinus congestion, runny nose, and sneezing
• Used for: ** **Claims based on traditional homeopathic practice, not accepted medical evidence
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

sodium chloride, the active ingredient in Pfizer (Australia) SODIUM CHLORIDE 0.9% (450mg/50mL) intravenous infusion, belongs to the alpha-Adrenergic Agonist class. INDICATIONS: May temporarily relieve sinus congestion, runny nose, and sneezing. ** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Pfizer (Australia) SODIUM CHLORIDE 0.9% (450mg/50mL) intravenous infusion. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Pfizer (Australia) SODIUM CHLORIDE 0.9% (450mg/50mL) intravenous infusion for extended periods without medical advice.